The NHS has strict rules about when it will prescribe Vitamin D — and most older adults fall outside them. This guide explains exactly what the guidelines say, why daily tablets often fall short as you age, and when a private Vitamin D injection makes clinical sense.
Vitamin D deficiency is one of the most widespread and consistently underdiagnosed nutritional problems in the UK. Our latitude means that meaningful UV-B sunlight — the only natural trigger for Vitamin D synthesis in skin — is only available between approximately April and September. For the other six months of the year, the body cannot produce meaningful amounts of Vitamin D regardless of sun exposure.
For adults over 65, this problem is compounded by several biological changes: the skin becomes less efficient at synthesising Vitamin D from UV-B as we age; the kidneys become less effective at converting Vitamin D to its active form (calcitriol); and gut absorption of fat-soluble vitamins including Vitamin D declines. The result is that older adults are at significantly higher risk of deficiency even compared to younger people with the same lifestyle.
Public Health England recommends that all adults, and especially those over 65, consider a daily supplement containing 10 micrograms (400 IU) of Vitamin D, particularly through autumn and winter. For housebound residents and those in care homes, this should be considered year-round.
The guidance sounds straightforward, but it contains a critical practical limitation: "Where to get it: You are expected to purchase these over the counter." The NHS does not routinely prescribe Vitamin D for prevention. NHS England policy is explicit that Vitamin D supplementation to prevent deficiency does not require the authorisation of a prescriber and is considered an over-the-counter (OTC) nutritional supplement.
NHS primary care will only prescribe Vitamin D in a limited set of clinical circumstances:
Outside these specific criteria, your GP will almost certainly direct you to purchase Vitamin D over the counter. For care home residents, care homes have a legal duty under the Health and Social Care Act Regulation 14 to provide Vitamin D supplementation where necessary — but this again typically means OTC supplements purchased on behalf of the resident.
Millions of older adults in the UK are Vitamin D insufficient — not yet meeting the clinical threshold for prescribed treatment, but low enough to experience fatigue, low mood, muscle weakness, and immune suppression. The NHS will not prescribe for them. OTC supplements are the expected solution. But for many over-65s, daily tablets are not enough.
The NHS expectation — take a 400 IU daily tablet — works well for younger adults with healthy gut function. For many people over 65, it is insufficient for several reasons:
Vitamin D is fat-soluble — it is absorbed alongside dietary fats. In older adults, both fat digestion and small intestinal absorption efficiency decline, meaning less of each tablet is absorbed than the label suggests.
The skin's capacity to synthesise Vitamin D from UV-B declines with age. An 80-year-old may produce only 25–30% of the Vitamin D from equivalent sun exposure compared to a 20-year-old.
The kidneys convert Vitamin D to its active form, calcitriol. Kidney function declines with age, and the efficiency of this activation step is reduced — meaning even adequate intake may not translate to adequate active Vitamin D.
Daily tablet regimens, particularly for older patients managing multiple medications, have notoriously variable compliance. Skipped doses and irregular intake make it difficult to maintain consistent Vitamin D levels.
A single intramuscular Vitamin D injection (Ergocalciferol or Cholecalciferol IM) delivers a high therapeutic dose — typically 300,000 IU — directly into the body, completely bypassing the gut and avoiding all the absorption limitations described above. For older adults who are deficient or insufficiently responding to daily tablets, an injection offers:
At £50, a twice-yearly Vitamin D injection at Lambert Medical Practice is a modest investment for meaningful protection against the wide-ranging consequences of deficiency — bone loss, immune suppression, fatigue, falls risk, and mood disturbance.
GP-administered IM injection. One injection covers 3–6 months. CQC registered. Surbiton KT6 7BE. Same-day availability.